UNIVERSITY OF CHICAGO
Imaging Feedback for Histotripsy Renal Tumor Ablation
Imaging Feedback for Histotripsy Renal Tumor Ablation is a funding opportunity from UNIVERSITY OF CHICAGO, up to 44589, closing March 31, 2029.
Mar 31, 2029
(974d left)Overview
PROJECT SUMMARY: Renal cell carcinoma (RCC) is the sixth most common cancer in the United States, with ~ 82k new diagnoses estimated for 2023. Surgery is the preferred option for initial management of RCC, but the number of patients who qualify is reduced each year due to the aging, comorbid population. Histotripsy is…